Navigation Links
Morgan & Morgan's Personal Injury Attorneys Provide Information About Yaz, Yasmin, and Ocella Injuries and Potential Health Risks
Date:2/24/2010

Popular birth control pills Yaz, Yasmin, and Ocella linked to potentially serious health risks. The injury lawyers at Morgan & Morgan are alerting consumers of these side effects and reviewing possible lawsuits.

(PRWEB) February 24, 2010 -- The attorneys at Morgan & Morgan, PA are currently evaluating potential legal claims for users of the birth control pills Yaz, Yasmin, and Ocella who have suffered serious side effects or injury. Yaz, Yasmin, and Ocella are once a day oral contraceptives that have been linked to dangerous health problems, including heart attacks, strokes, gallbladder problems, and blood clots.

Yasmin and Yaz are two separate but related birth control pills manufactured by Bayer Healthcare. Ocella is the generic version of Yasmin. These oral contraceptives, which are taken to prevent unwanted pregnancies, contain a different kind of hormone called drsp, or drospirenone. Drospirenone can cause increased potassium levels in some women, which can lead to health problems. People with kidney, liver, or adrenal disease are at an increased risk for developing negative Yaz side effects from using these birth control drugs.

Several Yaz lawsuits were filed in the summer of 2009, alleging that Bayer overstated the benefits of Yaz while failing to warn women that it could put them at risk for potentially life threatening injuries. It is expected that similar Yaz and Yasmin lawsuits will be filed in the future. Women may be entitled to financial compensation if they have suffered any of the following side effects: heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), gallbladder disease, or blood clot.

If you or a loved one has suffered serious medical problems after taking Yaz, Yasmin, or Ocella, you may have valuable legal rights. Visit ForThePeople.com and fill out the Free Case Evaluation form to find out if you are eligible to participate in a Yaz lawsuit. Morgan & Morgan’s Yaz and Yasmin lawyers are experienced in litigating dangerous and defective drug cases and have the resources and knowledge to pursue justice on your behalf.

About Morgan & Morgan

Morgan & Morgan is one of the largest Personal Injury law firms in the country with offices nationwide. The firm handles product liability cases, personal injury cases, and medical malpractice cases, as well as claims against drug and medical device manufacturers. Visit ForThePeople.com for a free case evaluation and information about your legal rights.

###

Read the full story at http://www.prweb.com/releases/florida-injury-lawyers/yaz-yasmin-injuries/prweb3642574.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Virginia House Majority Leader Morgan Griffith Sponsors Legislation Enabling Mobile Solution for Health Care SALEM, Va.
2. BMEGateway Celebrates its 20th Anniversary and Welcomes Dr. William Morgan
3. Emdeon to Present at the 28th Annual J.P. Morgan Healthcare Conference
4. Mindray Medical to Present at the 28th Annual J.P. Morgan Healthcare Conference and Jefferies 2010 Global Healthcare Services Conference
5. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
6. HealthSouth to Present at J.P. Morgan Healthcare Conference
7. Savient To Present at the 28th Annual JP Morgan Healthcare Conference
8. St. Andrews Country Club Announces Dates and Players for Third Annual Morgan & Friends Fight Cancer Tournament
9. Henry Schein to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Morgan & Morgan's Personal Injury Attorneys Provide Information About Yaz, Yasmin, and Ocella Injuries and Potential Health Risks 
(Date:5/6/2016)... ... 06, 2016 , ... Logically, spring weather, with its moderate humidity and temperatures, ... cold, dry or hot, water on the eye surface can evaporate, creating uncomfortable dry ... air. There’s only one problem, according to radio show and water advocate Sharon Kleyne: ...
(Date:5/6/2016)... ... , ... Canadian author Mark Black is a speaker, author, and life strategy coach ... world … with the help of his publisher Strategic Book Group and its subsidiary ... hospital bed waiting for a miracle: He needed a heart and double-lung transplant. From this ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl says ... it is his hope that the health and science industries will pay close attention and ...
(Date:5/6/2016)... ... 2016 , ... Kenneth Cochran, DSc, RN, FACHE, President/CEO of ... South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular Institute of ... Coronary Atherectomy. , This procedure involves the removal of plaque by ...
(Date:5/5/2016)... Tucson, AZ (PRWEB) , ... May 05, 2016 , ... ... more attention being paid to the impact our aging population has on communities and ... help aging adults plan for and face age-related challenges. , Aging Life Care ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology: